semaglutide 12.5mg The push for Medicare to cover weight-loss drugs: An explainer I think i have been

SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a market analysts expect to be worth billions in coming years.The injection belongs to the class of GLP-1 receptor agonist drugs sold locally by drugmakers such as Novo Nordisk, Eli Lilly, and Innovent Biologics

Perrinjaquet-Moccetti T, Wullschleger C, Schmidt A, Aydogan C, Kreuter M

It can go either way

But as they become more available, some people who don't have excess weight seek them, sometimes just to slim down